The company reported total revenues of $5,206 million for Q4 2023, up 5% from $4,938 million a year earlier, and net income attributable to GE HealthCare of $403 million versus $554 million in the prior year.

1. 01

   The company reported total revenues of $5,206 million for Q4 2023, up 5% from $4,938 million a year earlier, and net income attributable to GE HealthCare of $403 million versus $554 million in the prior year.

2. 02

   GE HealthCare said its full-year 2023 Adjusted EBIT margin was 15.1%, down 50 basis points from 15.6% a year earlier, and its net income margin was 8%, down 240 basis points from 10.4%. It attributed the decline in net income margin mainly to the impact of standalone interest expense.

3. 03

   The company said full-year 2023 cash flow from operating activities was $2.1 billion, down $33 million year over year, and free cash flow was $1.7 billion, down $113 million. It cited standalone interest and postretirement benefit payments as the reasons.

4. 04

   The company provided full-year 2024 guidance for Organic revenue growth of approximately 4%, Adjusted EBIT margin of 15.6% to 15.9%, Adjusted EPS of $4.20 to $4.35, and free cash flow of approximately $1.8 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.